ETAHX Mutual Fund

ETAHX Mutual Fund

NAV$57.89
See how much of ETAHX you already own
Just $25 once·$69/mo·Download sample
X-ray my portfolio free

Fund Essentials - as of Dec 31, 2025

Net Assets
$158M
Expense Ratio
1.56%
Dividend Yield (Current)
-
Holdings
90
Inception Date
Dec 27, 2012
Fund Family
Eventide
Investment Style
PRO
Asset Class
PRO
Legal Structure
PRO
Dividend Frequency
Annually

Performance

YTD+7.07%
1 Year+56.10%
3 Year+13.69%
5 Year+6.62%
10 Year+13.16%

Asset Allocation

Stocks: 93.43%
Bonds: 0.01%
Cash: 0.22%
Other: 6.34%
See how much of ETAHX you already own
Your funds unpacked, overlap, fees and score, free on screen. The full report is $25, once. Download sample.
X-ray my portfolio free

Top Holdings

View All →
TickerNameWeight
GHGuardant Health Inc4.46%
MIRMMirum Pharmaceuticals Inc3.60%
BBNXBeta Bionics Inc. Ser E3.19%
INSMInsmed Inc3.15%
-Medline Indust 10/23/2028 5.47 2028-10-233.11%
Top 10 Concentration: 30.70%Report Date: Dec 31, 2025
Download all 90 holdings for ETAHX
CSV export with sector, industry & share changes
Get CSV

Dividend Summary

View Details →
Frequency
Annually
Latest Distribution
$4.35
-

Peer Comparison

Benchmark
PRO
Peer outperformance: PRO
Category rank: PRO
This Mutual Fund
PRO
Peer Avg
PRO

ETAHX Mutual Fund Overview

ETAHX Mutual Fund (Eventide Healthcare & Life Sciences Fund Class A) is managed by Eventide with $157.5M in net assets. ETAHX expense ratio is 1.56%, holding 90 positions across sectors including Health Care. Inception date: 2012-12-27.

ETAHX performance shows a YTD return of 7.07%. The 1-year return is 56.10% and the 5-year return is 6.62%.

ETAHX top holdings include Guardant Health Inc (4.5%), Mirum Pharmaceuticals Inc (3.6%), Beta Bionics Inc. Ser E (3.2%), Insmed Inc (3.1%), Medline Indust 10/23/2028 5.47 2028-10-23 (3.1%). Go to all ETAHX holdings, ETAHX sectors, or ETAHX dividends.

ETAHX can be compared against other funds. Use ETAHX overlap to find shared positions, or ETAHX vs another fund for a side-by-side view. ETAHX alternatives are available via the screener, along with tax-loss harvesting opportunities.